GlassScriptPhysician profile
James R Monroe
NPI 1225067556
$5,112.91
in general payments reported to CMS, 2019-2025
27 companies · $866 in 2025
The $866 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $843 · 2020: $128 · 2021: $228 · 2022: $1,668 · 2023: $621 · 2024: $758 · 2025: $866.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,245.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,245.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,040.71 | 2019-2025 | Rezum Generator, Ams 700, Lithovue |
| Coloplast Corp | $633.51 | 2019-2024 | Titan, Saffron |
| Bayer Healthcare Pharmaceuticals INC. | $329.30 | 2019-2023 | |
| Calyxo, INC. | $328.38 | 2024-2025 | Cvac Aspiration System |
| Astellas Pharma US INC | $289.60 | 2019-2025 | Xtandi |
| Abbvie INC. | $228.57 | 2019-2023 | |
| Medtronic, INC. | $226.99 | 2022-2025 | Interstim |
| Endo Pharmaceuticals INC. | $171.92 | 2019-2023 | Xiaflex |
| Laborie Medical Technologies Corp. | $129.16 | 2020-2025 | Optilume Bph Drug Coated Balloon Catheter |
| Srs Medical Systems, INC. | $112.28 | 2024 | Urocuff-Dc Disposable, Single, Ct3000 Pro Base Unit |
| Bioprotect Medical, INC. | $90.87 | 2024 | Bioprotect Balloon Implant System |
| Janssen Biotech, INC. | $89.04 | 2019-2022 | |
| Urogen Pharma, INC. | $82.94 | 2022-2025 | |
| Antares Pharma, INC. | $55.11 | 2020-2022 | |
| Merck Sharp & Dohme LLC | $42.68 | 2023 | Welireg, Keytruda |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Endo USA, INC. | $41.92 | 2025 | Aveed, Xiaflex |
| Sumitomo Pharma America, INC. | $36.23 | 2023 | Gemtesa |
| Urovant Sciences INC | $25.63 | 2021-2022 | |
| Olympus America INC. | $22.20 | 2023 | Itind System |
| Halozyme INC | $22.12 | 2023 | |
| Novartis Pharmaceuticals Corporation | $19.15 | 2022 | |
| Ambu INC. | $18.11 | 2021-2023 | |
| Blue Earth Diagnostics | $17.83 | 2019 | |
| 180 Medical, INC. | $16.61 | 2019 | |
| Clarus Therapeutics INC. | $15.26 | 2021 | |
| Myriad Genetic Laboratories, INC. | $13.58 | 2022 | |
| Pfizer INC. | $13.21 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Monroe listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.